Table 1 |
|||||||
|
ASR(World) for incidence and mortality (per 100,000) for stomach, liver and cervical cancer during 1998-2003. |
|||||||
|
Age Standardized Rate (ASR) |
Standardized Relative Ratio SRR (95% CI) |
||||||
|
|
|||||||
|
PR |
NHW |
USH |
NHB |
NHW/PR |
USH/PR |
NHB/PR |
|
|
|
|||||||
|
Incidence |
|||||||
|
|
|||||||
|
Stomach |
|||||||
|
|
|||||||
|
Male |
22.53 |
11.71 |
20.13 |
20.22 |
0.52 (0.48-0.57) |
0.89 (0.79-1.01) |
0.90 (0.79-1.01) |
|
|
|||||||
|
Females |
11.00 |
5.51 |
12.51 |
12.86 |
0.50 (0.46-0.55) |
1.14 (1.00-1.29) |
1.17 (1.03-1.33) |
|
|
|||||||
|
SRR Ma vs Fb |
2.05 (1.82-2.30) |
2.13 (2.02-2.25) |
1.61 (1.42-1.83) |
1.57 (1.38-1.76) |
|||
|
|
|||||||
|
Liver |
|||||||
|
|
|||||||
|
Male |
11.89 |
6.96 |
14.23 |
12.20 |
0.59 (0.53-0.65) |
1.20 (1.05-1.37) |
1.03 (0.89-1.18) |
|
|
|||||||
|
Females |
5.94 |
2.95 |
6.40 |
4.21 |
0.50 (0.44-0.57) |
1.08 (0.91-1.27) |
0.71 (0.59-0.85) |
|
|
|||||||
|
SRR Ma vs Fb |
2.00 (1.72-2.33) |
2.44 (2.27-2.61) |
2.22 (1.92-2.59) |
2.92 (2.46-3.27) |
|||
|
|
|||||||
|
Cervix |
|||||||
|
|
|||||||
|
Females |
9.07 |
5.90 |
12.68 |
10.01 |
0.65 (0.60-0.70) |
1.40 (1.28-1.53) |
1.10 (0.99-1.23) |
|
|
|||||||
|
Mortality |
|||||||
|
|
|||||||
|
Stomach |
|||||||
|
|
|||||||
|
Male |
17.07 |
6.75 |
11.76 |
16.01 |
0.40 (0.36-0.43) |
0.69 (0.62-0.77) |
0.94 (0.85-1.04) |
|
|
|||||||
|
Female |
8.02 |
3.51 |
6.70 |
8.70 |
0.44 (0.39-0.49) |
0.84 (0.74-0.94) |
1.08 (0.97-1.22) |
|
|
|||||||
|
SRR Ma vs Fb |
2.13 (1.85-2.45) |
1.92 (1.88-1.97) |
1.76 (1.62-1.90) |
1.84 (1.75-1.92) |
|||
|
|
|||||||
|
Liver |
|||||||
|
|
|||||||
|
Male |
13.59 |
6.86 |
11.73 |
9.88 |
0.50 (0.46-0.55) |
0.86 (0.78-0.96) |
0.73 (0.66-0.80) |
|
|
|||||||
|
Females |
7.82 |
3.31 |
6.46 |
4.68 |
0.42 (0.38-0.47) |
0.83 (0.73-0.93) |
0.60 (0.53-0.67) |
|
|
|||||||
|
SRR Ma vs Fb |
1.73 (1.51-1.99) |
2.07 (2.03-2.12) |
1.81 (1.68-1.96) |
2.12 (1.99-2.22) |
|||
|
|
|||||||
|
Cervix |
|||||||
|
|
|||||||
|
Female |
2.38 |
2.11 |
3.36 |
5.12 |
0.89 (0.76-1.04) |
1.41 (1.20-1.68) |
2.16 (1.84-2.55) |
|
|
|||||||
|
aMale bFemale |
|||||||
|
Ortiz et al. Infectious Agents and Cancer 2010 5:10 doi:10.1186/1750-9378-5-10 |
|||||||